FDA Warning Letter: Mother Stem Institute, Corp.
type: Action
additional type: https://schema.org/RegulationAction
start time: 2024-09-03
description: Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps). Issued by FDA Center for Biologics Evaluation and Research (CBER) on 2024-08-20.
agent: FDA Center for Biologics Evaluation and Research (CBER)
object: Mother Stem Institute, Corp.
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
source organization: U.S. Food and Drug Administration
publisher: AI Analytics

PropertyValue
property ID: FDA Warning Letter ID
value: 1c546201d7fadec4

AI Analytics
type: Organization